Researcher.Life Logo

Journal of Applied Biomedicine : Impact Factor & More

eISSN: 1214-0287pISSN: 1214-021X
JournalOpen Access

Aims and Scope of Journal of Applied Biomedicine

The Journal of Applied Biomedicine is a peer-reviewed medical journal published quarterly by the University of South Bohemia. It covers fundamental biomedical research, clinical investigation and practice, as well as public health. The editor-in-chief is Josef Berger. Less

Key Metrics

CiteScore
3.4
Impact Factor
< 5
SJR
Q3Neuroscience (all)
SNIP
0.51
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Applied Biomedicine

Journal of Applied Biomedicine Journal Specifications

Overview
Publisher UNIV SOUTH BOHEMIA
Language English
Frequency Quarterly
Article Processing ChargesEUR 300
Publication Time30
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 30
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Journal of Applied Biomedicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Applied Biomedicine

Walking the tightrope: Balancing immune checkpoints and their inhibitors in host defence against bacterial infections.
  • 27 Mar 2026
  • Journal of applied biomedicine
MiR-500a-3p negatively regulates SOCS2 and participates in the proliferation, glycolysis, and apoptosis of HCC cells via the JAK2/STAT5 pathway.
  • 9 Mar 2026
  • Journal of applied biomedicine
Walking the tightrope: Balancing immune checkpoints and their inhibitors in host defence against bacterial infections.
  • 27 Mar 2026
  • Journal of applied biomedicine
MiR-500a-3p negatively regulates SOCS2 and participates in the proliferation, glycolysis, and apoptosis of HCC cells via the JAK2/STAT5 pathway.
  • 9 Mar 2026
  • Journal of applied biomedicine

FAQs on Journal of Applied Biomedicine